# Pelthos Therapeutics Inc. (PTHS): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Pelthos Therapeutics Inc. (PTHS) is 21/100, ranked against 24,000+ stocks in 35 markets (Quality 31, Value 30, Momentum 42, each scored against its sector).

- StockRank: 21/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 31, Value 30, Momentum 42: each a 0-100 percentile within Healthcare.
- Position: #20,990 overall, #1,889 in Healthcare.
- Listing: United States, ASE; Healthcare / Biotechnology.
- Last close: 15.2 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors bought USD 1000K; directors sold USD 149K.

Source: https://moatmap.ai/stock/PTHS
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker